Taiwo Oladapo

Array ( [id] => 9009353 [patent_doc_number] => 08524651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Method of therapy' [patent_app_type] => utility [patent_app_number] => 13/396254 [patent_app_country] => US [patent_app_date] => 2012-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17219 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13396254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477701 [patent_doc_number] => 20120277109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'PROXIMITY-MEDIATED ASSAYS FOR DETECTING ONCOGENIC FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/361881 [patent_app_country] => US [patent_app_date] => 2012-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 48012 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13361881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8476639 [patent_doc_number] => 20120276045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'TREATMENT OF SOLID CANCERS' [patent_app_type] => utility [patent_app_number] => 13/360914 [patent_app_country] => US [patent_app_date] => 2012-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15832 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13360914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8966300 [patent_doc_number] => RE044437 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2013-08-13 [patent_title] => 'Methods for detecting receptor complexes comprising PI3K' [patent_app_type] => reissue [patent_app_number] => 13/352705 [patent_app_country] => US [patent_app_date] => 2012-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 55 [patent_no_of_words] => 26542 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13352705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9192018 [patent_doc_number] => 20130331333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'PAR1 AND PAR2 C-TAIL PEPTIDES AND PEPTIDE MIMETICS' [patent_app_type] => utility [patent_app_number] => 13/977545 [patent_app_country] => US [patent_app_date] => 2011-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 17576 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13977545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8239872 [patent_doc_number] => 20120148613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'MULTIVALENT ENTRAIN-AND-AMPLIFY IMMUNOTHERAPEUTICS FOR CARCINOMA' [patent_app_type] => utility [patent_app_number] => 13/336523 [patent_app_country] => US [patent_app_date] => 2011-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 19679 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13336523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8144045 [patent_doc_number] => 20120096569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'ANTI-IL-6 ANTIBODIES,COMPOSITIONS, METHODS AND USES' [patent_app_type] => utility [patent_app_number] => 13/332973 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 32370 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20120096569.pdf [firstpage_image] =>[orig_patent_app_number] => 13332973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8323504 [patent_doc_number] => 20120195913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/326569 [patent_app_country] => US [patent_app_date] => 2011-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30750 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13326569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8300971 [patent_doc_number] => 20120183529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/326514 [patent_app_country] => US [patent_app_date] => 2011-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 30732 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13326514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8185228 [patent_doc_number] => 20120115165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'BIOMARKERS FOR DETECTION AND DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA' [patent_app_type] => utility [patent_app_number] => 13/324526 [patent_app_country] => US [patent_app_date] => 2011-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12178 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115165.pdf [firstpage_image] =>[orig_patent_app_number] => 13324526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10505261 [patent_doc_number] => 09233120 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-12 [patent_title] => 'Anti-CCL25 and anti-CCR9 antibodies for the prevention and treatment of cancer and cancer cell migration' [patent_app_type] => utility [patent_app_number] => 13/324633 [patent_app_country] => US [patent_app_date] => 2011-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 21388 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13324633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8221211 [patent_doc_number] => 20120135415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'DETECTING CANCER WITH ANTI-CXCL13 AND ANTI-CXCR5 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/313705 [patent_app_country] => US [patent_app_date] => 2011-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 19665 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13313705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094761 [patent_doc_number] => 20120082993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'DETECTING CANCER WITH ANTI-CXCL16 AND ANTI-CXCR6 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/312343 [patent_app_country] => US [patent_app_date] => 2011-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17079 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20120082993.pdf [firstpage_image] =>[orig_patent_app_number] => 13312343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8264736 [patent_doc_number] => 20120164160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/306545 [patent_app_country] => US [patent_app_date] => 2011-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 39533 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13306545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8566032 [patent_doc_number] => 20120328603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'ASSAYS AND METHODS USING BIOMARKERS' [patent_app_type] => utility [patent_app_number] => 13/303638 [patent_app_country] => US [patent_app_date] => 2011-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 26622 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13303638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8209006 [patent_doc_number] => 20120128665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'PRESELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT BASED ON HYPOXIC STATUS' [patent_app_type] => utility [patent_app_number] => 13/300221 [patent_app_country] => US [patent_app_date] => 2011-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 46026 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128665.pdf [firstpage_image] =>[orig_patent_app_number] => 13300221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8208920 [patent_doc_number] => 20120128580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'PRESELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT WITH ELESCLOMOL BASED ON HYPOXIC STATUS' [patent_app_type] => utility [patent_app_number] => 13/300231 [patent_app_country] => US [patent_app_date] => 2011-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23219 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128580.pdf [firstpage_image] =>[orig_patent_app_number] => 13300231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807538 [patent_doc_number] => 20120058492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'Method and a Kit To Detect Malignant Tumors and Provide a Prognosis' [patent_app_type] => utility [patent_app_number] => 13/290207 [patent_app_country] => US [patent_app_date] => 2011-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11580 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058492.pdf [firstpage_image] =>[orig_patent_app_number] => 13290207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784220 [patent_doc_number] => 20120045776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'MONOCLONAL ANTIBODY DS6, TUMOR-ASSOCIATED ANTIGEN CA6, AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/287633 [patent_app_country] => US [patent_app_date] => 2011-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10026 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20120045776.pdf [firstpage_image] =>[orig_patent_app_number] => 13287633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12100289 [patent_doc_number] => 09857380 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-02 [patent_title] => 'Profiling fragments of elastic fibers and microfibrils as biomarkers for disease' [patent_app_type] => utility [patent_app_number] => 13/280644 [patent_app_country] => US [patent_app_date] => 2011-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 55 [patent_no_of_words] => 15403 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13280644 [rel_patent_id] =>[rel_patent_doc_number] =>)